Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 69 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Cost-value analysis and the SAVE: a work in progress, but an option for localised decision making?Karnon, J.; Partington, A.
2012A proposed model for economic evaluations of major depressive disorderHajiali Afzali, H.; Karnon, J.; Gray, J.
2012Monitoring progress in the management of hip fractures in South Australia, AustraliaGordon, J.; Pham, C.; Karnon, J.; Crotty, M.
2012Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumabDelea, T.; Tappenden, P.; Sofrygin, O.; Karnon, J.; Browning, D.; Amonkar, M.; Walker, M.; Cameron, D.
2012Lifetime cost-utility analyses of deferasirox in beta-thalassaemia patients with chronic iron overload: A UK perspectiveKarnon, J.; Tolley, K.; Vieira, J.; Chandiwana, D.
2013A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetesHajiali Afzali, H.; Gray, J.; Beilby, J.; Holton, C.; Banham, D.; Karnon, J.
2010A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UKKarnon, J.; Holmes, M.; Williams, R.; Bakhai, A.; Brennan, A.
2012Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4Karnon, J.; Stahl, J.; Brennan, A.; Caro, J.; Mar, J.; Moller, J.
2012A model-based evaluation of collaborative care in management of patients with type 2 diabetes in Australia: an initial reportHajiali Afzali, H.; Karnon, J.; Gray, J.; Beilby, J.
2011The efficient price: an opportunity for funding reformKarnon, J.; Ben-Tovim, D.; Pham, C.; Caffrey, O.; Hakendorf, P.; Crotty, M.; Phillips, P.